Detalhe da pesquisa
1.
Diverse mutational landscapes in human lymphocytes.
Nature
; 608(7924): 724-732, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948631
2.
Identification and characterization of in vitro expanded hematopoietic stem cells.
EMBO Rep
; 23(10): e55502, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971894
3.
Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Exp Hematol
; : 104246, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763471
4.
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.
Nat Med
; 29(12): 3175-3183, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37973947
5.
Exploiting Single-Cell Tools in Gene and Cell Therapy.
Front Immunol
; 12: 702636, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322133
6.
Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim.
Hemasphere
; 7(8): e934, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37520777
7.
Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes.
J Leukoc Biol
; 102(2): 209-219, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596252
8.
Tet2 restrains inflammatory gene expression in macrophages.
Exp Hematol
; 55: 56-70.e13, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28826859
9.
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.
J Clin Oncol
; 35(24): 2745-2753, 2017 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28486043